Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Genetic epidemiology of esophageal adenocarcinoma.

EF 2011-12

Résumé
Esophageal cancer is increasing in frequency and is an extremely aggressive disease with among the worst prognosis of all cancers. Currently, there are few good ways to determine who how well individuals with the disease will fare or which therapies are best for which patients. This greatly hampers research into improving detection of the disease, clinical care of patients, and tailoring therapies. While other studies on this topic have been done, the results have had limited significance. In part, this is due to the fact that studies were small and looked at only one or a few genes at a time. We will address these crucial questions using improved study design and techniques. We will use the largest available study, a 7-country consortium (BEACON), which has recently collected genome-wide data. We will analyze markers using both traditional and innovative techniques, in particular looking at pathway-level associations (rather than individual genes) and leveraging techniques in bioinformatics. We hope to identify relevant prognostic and pharmacogenetic markers improve management of this terrible disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
255023
Name
Morgen Eric K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Genetic epidemiology of esophageal adenocarcinoma.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer; Esophageal Adenocarcinoma; Genetic Epidemiology; Translational Epidemiology
Abstract
Esophageal cancer is increasing in frequency and is an extremely aggressive disease with among the worst prognosis of all cancers. Currently, there are few good ways to determine who how well individuals with the disease will fare or which therapies are best for which patients. This greatly hampers research into improving detection of the disease, clinical care of patients, and tailoring therapies. While other studies on this topic have been done, the results have had limited significance. In part, this is due to the fact that studies were small and looked at only one or a few genes at a time. We will address these crucial questions using improved study design and techniques. We will use the largest available study, a 7-country consortium (BEACON), which has recently collected genome-wide data. We will analyze markers using both traditional and innovative techniques, in particular looking at pathway-level associations (rather than individual genes) and leveraging techniques in bioinformatics. We hope to identify relevant prognostic and pharmacogenetic markers improve management of this terrible disease.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Morgen, Eric K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~